{"success":true,"condition":"familial hypercholesterolemia","status_filter":"RECRUITING","phase_filter":"all","count":20,"trials":[{"nct_id":"NCT07421297","title":"A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia","status":"RECRUITING","phase":["PHASE3"],"sponsor":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","interventions":["SYH2053 injection","SYH2053 injection placebo"],"enrollment":760,"url":"https://clinicaltrials.gov/study/NCT07421297"},{"nct_id":"NCT07465263","title":"A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)","status":"RECRUITING","phase":["PHASE3"],"sponsor":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","interventions":["SYH2053 Injection","Placebo Injection"],"enrollment":135,"url":"https://clinicaltrials.gov/study/NCT07465263"},{"nct_id":"NCT06555120","title":"Screening for Familial Hypercholesterolemia in Children","status":"RECRUITING","phase":["NA"],"sponsor":"Centre Hospitalier Universitaire, Amiens","interventions":["blood sample"],"enrollment":300,"url":"https://clinicaltrials.gov/study/NCT06555120"},{"nct_id":"NCT04815005","title":"HoFH, the International Clinical Collaborators Registry","status":"RECRUITING","sponsor":"University of Pennsylvania","interventions":["Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence."],"enrollment":1000,"url":"https://clinicaltrials.gov/study/NCT04815005"},{"nct_id":"NCT06458010","title":"Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)","status":"RECRUITING","phase":["EARLY_PHASE1"],"sponsor":"RenJi Hospital","interventions":["YOLT-101"],"enrollment":20,"url":"https://clinicaltrials.gov/study/NCT06458010"},{"nct_id":"NCT01109368","title":"The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository","status":"RECRUITING","sponsor":"The Rogosin Institute","interventions":[],"enrollment":60,"url":"https://clinicaltrials.gov/study/NCT01109368"},{"nct_id":"NCT06546137","title":"National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry","status":"RECRUITING","sponsor":"Hospital do Coracao","interventions":["whole genome sequencing"],"enrollment":1211,"url":"https://clinicaltrials.gov/study/NCT06546137"},{"nct_id":"NCT06743659","title":"Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia","status":"RECRUITING","phase":["NA"],"sponsor":"Brigham and Women's Hospital","interventions":["Alert-based computerized decision support"],"enrollment":450,"url":"https://clinicaltrials.gov/study/NCT06743659"},{"nct_id":"NCT06634160","title":"Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia","status":"RECRUITING","sponsor":"Nantes University Hospital","interventions":["Fibroscan","Sample collection"],"enrollment":200,"url":"https://clinicaltrials.gov/study/NCT06634160"},{"nct_id":"NCT07086989","title":"Cardiovascular Risk in Children With Chronic Conditions Study","status":"RECRUITING","sponsor":"Semmelweis University","interventions":[],"enrollment":300,"url":"https://clinicaltrials.gov/study/NCT07086989"},{"nct_id":"NCT07470723","title":"The ORIGIN-FH Study","status":"RECRUITING","phase":["NA"],"sponsor":"University of Wisconsin, Madison","interventions":["Screening for FH"],"enrollment":70,"url":"https://clinicaltrials.gov/study/NCT07470723"},{"nct_id":"NCT02009345","title":"Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","interventions":[],"enrollment":6000,"url":"https://clinicaltrials.gov/study/NCT02009345"},{"nct_id":"NCT05614219","title":"Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.","status":"RECRUITING","phase":["NA"],"sponsor":"Odense University Hospital","interventions":["Biochemistry interpretive comment on elevated LDL-C levels"],"enrollment":2000,"url":"https://clinicaltrials.gov/study/NCT05614219"},{"nct_id":"NCT04370899","title":"Early Detection of Familial Hypercholesterolemia in Children","status":"RECRUITING","sponsor":"Institut Investigacio Sanitaria Pere Virgili","interventions":["lifestyle assessment"],"enrollment":400,"url":"https://clinicaltrials.gov/study/NCT04370899"},{"nct_id":"NCT05348564","title":"Comparing Direct vs Indirect Methods for Cascade Screening","status":"RECRUITING","phase":["NA"],"sponsor":"University of Maryland, Baltimore","interventions":["Direct contact of family members for cascade screening of relevant variants"],"enrollment":200,"url":"https://clinicaltrials.gov/study/NCT05348564"},{"nct_id":"NCT07614958","title":"Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days","status":"RECRUITING","phase":["PHASE3"],"sponsor":"A. Menarini International Licensing S.A.","interventions":["Obicetrapib 10 mg/Bempedoic Acid Placebo","Bempedoic Acid 180mg/Placebo Obicetrapib"],"enrollment":426,"url":"https://clinicaltrials.gov/study/NCT07614958"},{"nct_id":"NCT07543731","title":"A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","interventions":[],"enrollment":5995,"url":"https://clinicaltrials.gov/study/NCT07543731"},{"nct_id":"NCT06597019","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia","status":"RECRUITING","phase":["PHASE3"],"sponsor":"Novartis Pharmaceuticals","interventions":["Inclisiran","Placebo"],"enrollment":60,"url":"https://clinicaltrials.gov/study/NCT06597019"},{"nct_id":"NCT07489209","title":"A Dose-exploration Study of EDP167 in HoFH","status":"RECRUITING","phase":["PHASE2"],"sponsor":"Eddingpharm (Zhuhai) Co., Ltd.","interventions":["EDP167"],"enrollment":20,"url":"https://clinicaltrials.gov/study/NCT07489209"},{"nct_id":"NCT03989167","title":"Clinical Decision Support for Familial Hypercholesterolemia","status":"RECRUITING","phase":["NA"],"sponsor":"University Hospital, Linkoeping","interventions":["Clinical decision support"],"enrollment":460000,"url":"https://clinicaltrials.gov/study/NCT03989167"}],"source":"ClinicalTrials.gov"}